
Pfizer's Paxlovid still free, for now, after FDA grants full approval to COVID drug
CBSN
The Biden administration will continue to manage the distribution of free courses of Pfizer's Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the Food and Drug Administration granted Pfizer full approval Thursday to market the pills.
"At this time, the U.S. government will continue to oversee the distribution of PAXLOVID, and U.S. residents eligible for PAXLOVID will continue to receive the medicine at no charge," Pfizer said in a release.
Federal officials have previously said that the widely-expected approval of the drug, as well as the unwinding of the public health emergency earlier this month, would have no immediate impact on distribution of government-bought supplies of the pills.

People in New York City and across the northeastern United States woke up Tuesday morning to an unusual sight. Depending on the time, early risers reported witnessing either the moon or the sun bearing a reddish glow. It was not the first time in recent weeks that both the sun and the moon have turned red in skies over various parts of the Northeast and the Pacific Northwest, as wildfires burning in eastern and western Canada continue to send smoke down the border.

For the first time in its more than 40-year history, the Human Rights Campaign on Tuesday declared a "state of emergency" for LGBTQ+ Americans, issuing a guidebook alongside the national warning to help ensure safety for both LGBTQ+ residents and travelers alike. The news comes as LGBTQ+ Americans across the country begin to celebrate Pride Month.